Neurocrine Biosciences (NBIX) Interest Coverage Ratio Growth (1y) (2018 - 2024)
Neurocrine Biosciences (NBIX) Interest Coverage Ratio Growth (1y) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -14.04% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 73.06% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -13.48% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -21.30% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 224.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 186.95% |
| Dec 31, 2023 | 45.36% |
| Sep 30, 2023 | 75.44% |
| Jun 30, 2023 | 127.70% |
| Mar 31, 2023 | -8,807.33% |
| Dec 31, 2022 | 1,809.09% |
| Sep 30, 2022 | 985.17% |
| Jun 30, 2022 | 145.47% |
| Mar 31, 2022 | -75.78% |
| Dec 31, 2021 | -159.75% |
| Sep 30, 2021 | 229.37% |
| Jun 30, 2021 | 9.75% |
| Mar 31, 2021 | -31.48% |
| Dec 31, 2020 | 54.68% |
| Sep 30, 2020 | -146.28% |
| Jun 30, 2020 | 111.94% |
| Mar 31, 2020 | 156.18% |
| Dec 31, 2019 | 111.34% |
| Sep 30, 2019 | 59.06% |
| Jun 30, 2019 | 1,884.80% |